AOD-9604
Also known as hGH fragment 176-191
Growth hormone fragment marketed for fat metabolism.
- Category
- fat loss
- Route
- subq
- Documented dose
- 300–500 mcg
- Typical frequency
- Once daily fasted
- Cycle
- 12 weeks on, 4 off
- Half-life
- ~30 minutes
- Common vial sizes
- 2 mg, 5 mg
- Regulatory status
- Not approved as a drug; some food-supplement status claims.
What it does
A trimmed-down piece of the growth hormone molecule. It keeps the part that tells fat cells to release stored fat, but leaves out the part that raises blood sugar or makes tissue grow. What people look into it for: • Burning stored body fat and slowing new fat storage • Fat loss without the appetite, water retention or blood-sugar changes seen with full growth hormone • Joint and cartilage comfort (early research only) Human weight-loss trials have been modest, so expectations should stay realistic.
Mechanism
C-terminal hGH fragment thought to stimulate lipolysis and inhibit lipogenesis.
Storage — lyophilised
Refrigerate 2-8C, protect from light.
Storage — reconstituted
Refrigerate 2-8C, use within ~28 days.
Reconstitution notes
Add 2 ml bacteriostatic water to a 5 mg vial for 25 mcg per unit.
Commonly stacked with
- Ipamorelin
Commonly reported side effects
- Injection-site reactions
- Headache
Contraindications noted
- Pregnancy or breastfeeding
Research notes
Human trials failed to show meaningful weight loss versus placebo.
Track this properly
Work out syringe units with the free calculator, or set up a full schedule in about a minute.
Reference information only, not medical advice. See our medical disclaimer.